The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G(2)/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells

Samankaltaisia teoksia

• The Investigational Aurora Kinase A Inhibitor Alisertib (MLN8237) Induces Cell Cycle G2/M Arrest, Apoptosis, and Autophagy via p38 MAPK and Akt/mTOR Signaling Pathways in Human Breast Cancer Cells [Retraction]
  Tekijä: Li J, et al.
  Julkaistu: (2025-10-01)
• Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway
  Tekijä: Niu, Ning-Kui, et al.
  Julkaistu: (2015)
• MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
  Tekijä: Sells, Todd B., et al.
  Julkaistu: (2015)
• Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway
  Tekijä: Niu NK, et al.
  Julkaistu: (2015-03-01)
• Alisertib induces G(2)/M arrest, apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells
  Tekijä: Liu, Zheng, et al.
  Julkaistu: (2017)